BDNF, GDNF, and VEGF in Muller Cell Viability: Implication in Neuroprotection in Diabetic Retinopathy and in Anti-VEGF Therapies

被引：0
|
作者：
Le, Yun-Zheng
Zhu, Meili
机构：
来源：
DIABETES | 2017年 / 66卷
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
40-LB
引用
收藏
页码：LB10 / LB11
页数：2
相关论文
共 50 条
  • [41] Using the Past to Inform the Future: Anti-VEGF Therapy as a Road Map to Develop Novel Therapies for Diabetic Retinopathy
    Titchenell, Paul M.
    Antonetti, David A.
    DIABETES, 2013, 62 (06) : 1808 - 1815
  • [42] Thinning of the central neurosensory retina during anti-VEGF treatment of diabetic retinopathy
    Prager, Sonja Gudrun
    Schuster, Magdalena
    Mitsch, Christoph
    Lammer, Jan
    Scholda, Christoph D.
    Schmidt-Erfurth, Ursula
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [43] Anti-VEGF for diabetic retinopathy treatment: systematic review of randomized controlled trials
    Le, Laura
    Latkany, Paul
    Kothari, Nikisha
    Scott, Nathan
    Rodriguez, Marianeli
    Patel, Nimesh
    Yannuzzi, Nicolas
    Haskova, Zdenka
    Callaway, Natalia
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [44] Modulation of Fibrosis and Neovascularization by Bevacizumab Anti-VEGF Blockade in Proliferative Diabetic Retinopathy
    Ianopol, N.
    Kirchhof, B.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [45] Anti-VEGF Pharmacotherapy as an Alternative to Panretinal Laser Photocoagulation for Proliferative Diabetic Retinopathy
    Olsen, Timothy W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (20): : 2135 - 2136
  • [46] Anti-VEGF therapy for proliferative diabetic retinopathy in Kearns-Sayre syndrome
    Leung, Vannessa
    Wong, James G.
    Grigg, John R.
    DOCUMENTA OPHTHALMOLOGICA, 2025, 150 (01) : 41 - 46
  • [47] Intravitreous anti-VEGF for diabetic retinopathy:: hopes and fears for a new therapeutic strategy
    Simo, R.
    Hernandez, C.
    DIABETOLOGIA, 2008, 51 (09) : 1574 - 1580
  • [48] Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy
    R. Simó
    C. Hernández
    Diabetologia, 2008, 51
  • [49] Epiretinal Membrane Is Associated with Diabetic Retinopathy Severity and Cumulative Anti-VEGF Injections
    Kakihara, Shinji
    Abdelsalam, Mohamed
    Zhuang, Kallista
    Fawzi, Amani A.
    OPHTHALMOLOGY SCIENCE, 2025, 5 (03):
  • [50] Anti-VEGF therapies, cancer and renal function
    Ayllon, J.
    Janus, N.
    Launay-Vacher, V.
    Medioni, J.
    Deray, G.
    Isnard-Bagnis, C.
    Oudard, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345